The groundbreaking I-SPY trials for neoadjuvant breast cancer treatment show there is no difference in recurrence rates between those who undergo mastectomy versus those who undergo lumpectomy. A surprising discovery for researchers and clinicians alike.
As advances in breast cancer treatment have allowed for a greater focus on quality of life and breast conservation, the roles of breast and plastic surgery seem to be increasingly intertwined. And all patients have the right to reconstruction after mastectomy.
There is a critical need for better collaboration and care between healthcare providers, community leaders, and the public, in order to tackle these issues and reduce cancer through prevention, education, and access.
New markers found in cancer-associated cells could make it easier for doctors to treat breast cancer, results of a new study published in Cancer Cell suggest. These new types of identifiers will help target chemotherapy by allowing doctors to better differentiate between healthy/normal tissue and cells contributing to cancer.